Sleep, Glucose, and Brain Health in Obesity and Overweight Individuals
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-65
SponsorUppsala University
About this trial
The primary aim of the NNF study is to investigate both cross-sectional and longitudinal associations between sleep patterns-measured over two consecutive weeks at baseline and again one year later-and indicators of glycemic control and brain health in a cohort of middle-aged adults. Through this effort, the investigators hope to identify potential sleep-related biomarkers and behavioral targets for early intervention to support metabolic and cognitive health.
Eligibility criteria
Qualifiers
Be between 40 and 65 years of age
Be classified as having normal weight, overweight, or obesity
Not be pregnant
Not be currently using glucose-lowering medications or undergoing glucose therapy
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov